Login to Your Account


Act does a good job of helping to catalyze flow of biotech IPOs

By Peter Winter

Monday, August 11, 2014

The Jumpstart Our Business Startups (JOBS) Act has had an extremely positive influence on the growth prospects for emerging biotechnology companies since it came into being in 2012. In fact, there has been a tidal wave of companies who have successfully completed their initial public offerings (IPOs) since its introduction.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription